The Spanish Association of Biosimilars (Biosim) is convinced that the arrival of biosimilars and, especially, the trust that years of use has established in professionals, as well as the reduction of the economic impact of treatment with biological medicines, is an opportunity to advance lines in the treatment of multiple diseases so that patients benefit at the appropriate time from the use of a biological.

READ MORE